$Allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma in children: A prospective, single arm study from India$

Allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma in children: A prospective, single arm study from India

Bibliographic Details
Main Authors:	Kavitha Ganesan, Suresh R. Duraisamy, Sohini Chakraborty, Satish Kumar Meena, V.S. Venkateswaran, Ramya Uppuluri, Revathi Raj
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S246812452200331X

Similar Items

Pulse dexamethasone and lenalidomide in Rosai Dorfman disease: Efficacy and tolerability of an oral combination chemotherapy regimen for symptomatic and recurrent disease
by: Kavitha Ganesan, et al.
Published: (2022-01-01)

First case series of low dose monthly Emicizumab prophylaxis in von Willebrand disease type III
by: Ganesan Kavitha, et al.
Published: (2022-01-01)

A novel risk stratification based therapy relevant to India for children with E beta thalassemia
by: Kavitha Ganesan, et al.
Published: (2022-01-01)

Genital graft versus host disease in children an underdiagnosed and undertreated entity
by: Kavitha Ganesan, et al.
Published: (2022-01-01)

Treatment free remission in pediatric chronic myeloid leukemia
by: Meena Satishkumar, et al.
Published: (2023-03-01)

Real world data on outcomes children with relapsed acute lymphoblastic leukemia over two decades
by: R.D. Suresh, et al.
Published: (2022-01-01)

Protocol and immunohistochemistry-based diagnosis and treatment of Non-Hodgkin lymphoma in children: Experience over two decades from a tertiary referral centre in South India
by: R.D. Suresh, et al.
Published: (2022-01-01)

Haploidentical stem cell transplantation in newly diagnosed high-risk neuroblastoma: Results from a single-arm, prospective study from India
by: R.D. Suresh, et al.
Published: (2022-01-01)

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
by: Taha Al-Juhaishi, et al.
Published: (2022-01-01)

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
by: Muhammad Salman Faisal, et al.
Published: (2023-04-01)

Haematopoietic stem cell transplantation and vaccine related infections in children with inborn errors of immunity
by: R.D. Suresh, et al.
Published: (2022-01-01)

Relapsed/Refractory Hodgkin Lymphoma
by: Semira Sheikh, et al.
Published: (2018-06-01)

Half matched but twice as good – Haploidentical stem cell transplantation for benign disorders in children – Challenges and outcome from a tertiary care centre in India
by: Ramya Uppuluri, et al.
Published: (2016-01-01)

Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
by: Federica Giannotti, et al.
Published: (2024-03-01)

Successful matched unrelated donor hematopoietic stem cell transplantation for infantile Wolman disease
by: Indira Jayakumar, et al.
Published: (2023-03-01)

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01)

Reduced toxicity and excellent outcomes using a treosulphan based conditioning regimen and unrelated haematopoietic stem cell transplantation in children with thalassaemia major
by: V.S. Venkateswaran, et al.
Published: (2016-01-01)

PB2435: ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES IN HODGKIN LYMPHOMA: A PROGNOSTIC STUDY OF 30 PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Shayan Zamani, et al.
Published: (2023-08-01)

LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY
by: Ayse Uysal, et al.
Published: (2023-10-01)

The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
by: Gi-June Min, et al.
Published: (2023-10-01)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
by: Timothy J Voorhees, et al.
Published: (2020-10-01)

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA
by: Sabine Kayser, et al.
Published: (2023-08-01)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
by: Simon Hallam
Published: (2018-08-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

Targeted therapy and hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in pediatric and adolescent patients: a pilot protocol results
by: Natalia S. Tsaplina, et al.
Published: (2023-05-01)

Nivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences
by: Ramazan Acar, et al.
Published: (2020-12-01)

PB2064: RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH RADIOTHERAPY
by: F. Kallel, et al.
Published: (2022-06-01)

Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
by: Michael P. Randall, et al.
Published: (2023-09-01)

Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma
by: Sonja Genadieva Stavrik, et al.
Published: (2021-10-01)

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
by: Jeremy A. Meier, et al.
Published: (2022-02-01)

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
by: Esther Hazane Leroyer, et al.
Published: (2022-11-01)

Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin’s Lymphoma
by: Sabine Mai, et al.
Published: (2013-06-01)

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
by: Yujie Zhang, et al.
Published: (2022-07-01)

T028 (0163) ALLOGENEIC STEM CELL TRANSPLANTATION (Allo-SCT) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (cHL) PATIENTS TREATED WITH NIVOLUMAB IS ASSOCIATED WITH AN UNPRECEDENTED LOW RELAPSE RATE
Published: (2018-10-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
by: Simona Pagliuca, et al.
Published: (2023-05-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Enrico Maffini, et al.
Published: (2022-11-01)

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results
by: Zhihui Li, et al.
Published: (2023-01-01)

TARGETED THERAPY WITH BRENTUXIMAB VEDOTIN IN RELAPSED AND REFRACTORY FORMS OF CLASSICAL HODGKIN LYMPHOMA
by: E. A. Demina
Published: (2017-11-01)

CLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF PEDIATRIC RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMAS
by: T. T. Valiev
Published: (2018-07-01)